leucine has been researched along with Thromboembolism in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (66.67) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
HAUSAMMANN, E | 1 |
KONIGS, J | 1 |
DICK, W; MATIS, P; MAYER, W | 1 |
DAMMANN, F; MOSTERT, H | 1 |
BRENNER, GL; MAGISTRIS, F | 1 |
KRULL, J; RUBELI, HH | 1 |
Anderson, JL; Doucette, SP; Gagnon, F; Scarvelis, DK; Wells, PS | 1 |
Anderson, JL; Carson, N; Doucette, SP; Grimwood, RL; Rodger, MA; Wells, PS | 1 |
Caso, R; Dawes, J; Lane, DA; Morris, HR; Olds, RJ; Panico, M; Sas, G; Thein, SL | 1 |
1 review(s) available for leucine and Thromboembolism
Article | Year |
---|---|
Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis.
Topics: Amino Acid Substitution; Factor XIII; Genetic Predisposition to Disease; Genetic Variation; Genotype; Humans; Leucine; Point Mutation; Polymorphism, Genetic; Risk Factors; Thromboembolism; Valine; Venous Thrombosis | 2006 |
8 other study(ies) available for leucine and Thromboembolism
Article | Year |
---|---|
[Prevention of thromboembolic complications in surgery with PH 203 (panthesin and hydergin)].
Topics: Aminobenzoates; Anticoagulants; Dihydroergotoxine; Drug Combinations; Ergot Alkaloids; Leucine; para-Aminobenzoates; Procaine; Thromboembolism | 1957 |
[Panthesin-hydergine therapy of thromboembolism].
Topics: Aminobenzoates; Ergoloid Mesylates; Ergot Alkaloids; Humans; Leucine; para-Aminobenzoates; Thromboembolism | 1957 |
[Results of alternating thromboembolism prophylaxis with panthesin-hydergine].
Topics: Anticoagulants; Ergoloid Mesylates; Ergot Alkaloids; Leucine; para-Aminobenzoates; Thromboembolism | 1961 |
[Contribution to the pathogenesis of thromboembolism and to its prophylaxis by panthesin-hydergin].
Topics: Anesthetics; Anesthetics, Local; Anticoagulants; Ergot Alkaloids; Leucine; para-Aminobenzoates; Thromboembolism | 1959 |
[Thromboembolism prevention in surgery. Results with panthesin-hydergin (PH 203) in 1048 patients].
Topics: 4-Aminobenzoic Acid; Dihydroergotoxine; Drug Combinations; Ergot Alkaloids; Leucine; para-Aminobenzoates; Procaine; Thromboembolism | 1960 |
[On the prophylaxis and therapy of thromboembolism. Experiences with PH 203 (panthesin plus hydergine)].
Topics: Aminosalicylic Acid; Dihydroergotoxine; Drug Combinations; Ergoloid Mesylates; Leucine; para-Aminobenzoates; Procaine; Thromboembolism | 1959 |
The factor XIII Val34Leu polymorphism: is it protective against idiopathic venous thromboembolism?
Topics: Amino Acid Substitution; Case-Control Studies; Factor XIII; Female; Genetic Predisposition to Disease; Genotype; Humans; Leucine; Male; Middle Aged; Odds Ratio; Polymorphism, Genetic; Risk Assessment; Thromboembolism; Valine; Venous Thrombosis; White People | 2006 |
Antithrombin III Budapest: a single amino acid substitution (429Pro to Leu) in a region highly conserved in the serpin family.
Topics: Amino Acid Sequence; Antibodies, Monoclonal; Antithrombin III; Base Sequence; DNA; Heparin; Homozygote; Humans; Leucine; Male; Molecular Sequence Data; Mutation; Proline; Thrombin; Thromboembolism | 1992 |